ENDOCRINOL DIAB META 润色咨询

Endocrinology Diabetes and Metabolism Case Reports

出版年份:暂无数据 年文章数:707 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2022年中国人文章占该期刊总数量100.00%
自引率
暂无数据
年文章数
707
期刊官网
点击查看 (点击次数:169)
点击查看 (点击次数:204次)
作者需知
点击查看 (点击次数:135次)
偏重的研究方向
暂无数据
期刊简介
稿件收录要求

Endocrinology, Diabetes & Metabolism Case Reports publishes case reports on common and rare conditions in all areas of clinical endocrinology, diabetes and metabolism.

Articles should include clear learning points which readers can use to inform medical education or clinical practice. The types of cases of interest to Endocrinology, Diabetes & Metabolism Case Reports include:

  •     Insight into disease pathogenesis or mechanism of therapy
  •     Novel diagnostic procedure
  •     Novel treatment
  •     Unique/unexpected symptoms or presentations of a disease
  •     New disease or syndrome: presentations/diagnosis/management
  •     Unusual effects of medical treatment
  •     Error in diagnosis/pitfalls and caveats

Articles reporting a single case to a case series will be considered.

Endocrinology, Diabetes & Metabolism Case Reports is unique in bringing together international and national endocrinology, diabetes and metabolism societies to collaborate on this publication in order to benefit those societies, their members and the community as a whole. One of these benefits is that members of collaborating societies enjoy a discount on the publishing fees.

Abstracting and indexing

Endocrinology, Diabetes & Metabolism Case Reports online ISSN: 2052-0573

Published articles are fully referenced and linked to a wide variety of discoverability services. 

Endocrinology, Diabetes & Metabolism Case Reports is indexed in a wide variety of relevant databases, these include: Directory of Open Access Journals, Web of Science’s Emerging Sources Citation Index (ESCI), Google Scholar, HINARI, PubMed, PubMed Central, and SCImago. We anticipate future indexing by Medline, which will be applied to all published articles retrospectively.

Research journal editorial policies usually restrict all but a few (if any) case reports being published so as not to waste valuable space or stunt impact factor growth. As case reports are not highly cited (despite being widely read), we do not expect this publication to be considered for an impact factor by Clarivate. Rather, Endocrinology, Diabetes & Metabolism Case Reports will provide a welcome publishing outlet for authors’ case reports, and will not be restricting the number of high-quality case reports published.